Primers and Probes for Detecting Genital Hpv Genotypes
AssigneeGreiner Bio-One GmbH
InventorsWolfgang Kranewitter, Christian Mittermayr, Florian Winner, Thomas Iftner
Life of this patent
Estimating the term…
Loading patent…
AssigneeGreiner Bio-One GmbH
InventorsWolfgang Kranewitter, Christian Mittermayr, Florian Winner, Thomas Iftner
Estimating the term…
The invention relates to oligonucleotides, which are suited as primers for amplifying DNA of genital human papilloma viruses (HPV), to oligonucleotides, which are suited for use as probes for typifying genital HPV genotypes, to methods for amplifying the DNA of genital human papilloma viruses (HPV), to methods for detecting and/or identifying genital HPV genotypes, to nucleotide microarrays containing the oligonucleotides, to kits and to the use of the oligonucleotides for amplifying or typifying genital HPV genotypes, for the diagnosis and/or early diagnosis of diseases and for producing agents for diagnosing diseases.
An oligonucleotide that may be used as a primer, in particular a forward primer, to amplify a nucleic acid region of a genital human papilloma virus (HPV) and that has the sequence 5′-CAR GCI AAA WWW KTD MR GAY TGT G-3′, or 5′-CAR GCN AAA WWW KTD MR GAY TGT G-3′ (SEQ ID no. 1), wherein R=A, or G, W=T, or A, K=T, or G, I=inosine, N=A, T, G, or C, D=A, T, or G, and Y=C, or T.
An oligonucleotide that may be used as a primer, in particular a reverse primer, to amplify a nucleic acid region of a genital human papilloma virus having the nucleotide sequence 5′-ARY GGY TSY ARC CM AAR TGR CT-3′ (SEQ ID no. 7), wherein R=A, or G, Y=C, or T, and S=C, or G.
An oligonucleotide that may be used as a probe for detecting and/or for identifying genital HPV genotypes selected from the group comprising:
A nucleic acid molecule comprising at least one region that has one of the nucleotide sequences recited in SEQ ID nos. 19, 32, 41, 44, 48, 82, or 117 to 135, a mutated nucleotide sequence thereof, obtained through the deletion and/or addition of 1 to 10 nucleotides and/or the substitution of 1 to 3 nucleotides in one of the nucleotide sequences recited in SEQ ID nos. 19, 32, 41, 44, 48, 82, or 117 to 135 or a complementary nucleotide sequence thereof and one or more additional regions having a total length of at least 1 nucleotide.
Dependencies are inferred from the claim text.